High Medicare Part D Drug Prices Are Inflating Pharmaceutical Industry Profits
Seeking Alpha | March 30, 2017
Medicare Part D is costing taxpayers more than $10 billion dollars a year in excess reimbursements relative to the Federal Supply Schedule used by other agencies for the same drugs.